Geneva Advisors’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$2.07M Sell
14,895
-30
-0.2% -$4.12K 0.04% 214
2017
Q1
$1.97M Sell
14,925
-111
-0.7% -$14K 0.04% 212
2016
Q4
$1.8M Buy
15,036
+209
+1% +$24K 0.04% 229
2016
Q3
$1.73M Sell
14,827
-5,512
-27% -$642K 0.03% 222
2016
Q2
$2.44M Buy
20,339
+2,155
+12% +$241K 0.05% 172
2016
Q1
$1.95M Buy
18,184
+3,160
+21% +$311K 0.04% 194
2015
Q4
$1.4M Sell
15,024
-847
-5% -$81.1K 0.03% 250
2015
Q3
$1.49M Buy
15,871
+597
+4% +$59.1K 0.03% 238
2015
Q2
$1.46M Sell
15,274
-362
-2% -$34.3K 0.03% 249
2015
Q1
$1.44M Buy
15,636
+1,705
+12% +$159K 0.03% 248
2014
Q4
$1.31M Buy
13,931
+3,784
+37% +$336K 0.02% 252
2014
Q3
$819K Hold
10,147
0.02% 343
2014
Q2
$856K Buy
10,147
+1,400
+16% +$114K 0.02% 334
2014
Q1
$713K Buy
8,747
+1,977
+29% +$157K 0.01% 333
2013
Q4
$509K Hold
6,770
0.01% 331
2013
Q3
$458K Sell
6,770
-540
-7% -$37.3K 0.01% 347
2013
Q2
$473K Buy
+7,310
New +$485K 0.01% 288

Other funds holding SYK

Geneva Advisors's SYK Position: Q2 2017 in Review

Geneva Advisors reduced its Stryker (SYK) stake by 0.2% in Q2 2017, selling an estimated $4.12K and leaving 14,895 shares worth $2.07M. The position accounts for 0.04% of the portfolio, ranked #214.

Geneva Advisors first reported a position in SYK in Q2 2013 and has held it in 17 quarters since. The position peaked at $2.44M in Q2 2016. 1,043 funds tracked by Wall St. Rank hold SYK as of Q2 2017.

  • Geneva Advisors held 14,895 shares of Stryker worth $2.07M as of Q2 2017.
  • Geneva Advisors sold 30 Stryker shares in Q2 2017, an estimated $4.12K.
  • Stryker made up 0.04% of Geneva Advisors's portfolio in Q2 2017, its #214 holding.
  • Geneva Advisors first reported a position in Stryker in Q2 2013 and has held it in 17 quarters since.
  • Geneva Advisors's Stryker position peaked at $2.44M in Q2 2016.
  • 1,043 funds tracked by Wall St. Rank held Stryker as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.